Company intelligence / Profile preview

Lifecare

Bergen, Vestland, Norway

Ownership: Private
Development stage: Other

Overview

Lifecare is developing and clinically testing the Sencell sensor platform for continuous monitoring of glucose, aiming to offer next-generation CGM systems. Veterinary adaptation is underway in collaboration with Norwegian University of Life Sciences.

Therapeutic areas: EndocrinologyMetabolic Disorders
Modalities: DeviceNanogranular tunneling resistive sensorSensor platform
Industry: Physiological Monitoring

Partnerships

University of Bath (UK, supramolecular chemistry)Norwegian University of Life Sciences (veterinary R&D)

Beyond the preview

Go deeper on Lifecare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lifecare.

Explore the full profile